A Liverpool-based pet health-tech platform, which was established in 2020, is about to variety its B2B buyer base after securing a six-figure funding from River Capital’s AI-focused fund.
Vidivet offers on-line vet triage companies to pet homeowners – 24 hours a day, seven days per week.
Established by Ben Sweeney, the corporate employs a crew of 60, together with a world crew of vets who work remotely.
The finance has been deployed from fund:AI, which was established final December with the intention of “levelling up AI”. Following its launch, River Capital funding director David Walters advised Insider that the fund will focus particularly on early-stage, excessive progress synthetic intelligence, machine studying and knowledge science funding alternatives.
The capital will help Vidivet throughout its interval of speedy progress because it secures a variety of new B2B purchasers and enters into the pet insurance coverage ecosystem.
AI experience can even be provided to speed up Vidivet’s plans to reinforce its vet service and enhance buyer satisfaction ranges.
Walters led on the funding, and was supported by Daniel Hayhurst of Brabners and Mike McMahon of Trowers & Hamlins.
Chief government Ben Sweeney stated: “Raising funding may be arduous and lots of founders inevitably discover it troublesome to pick the fitting companion to pursue their imaginative and prescient. From early conferences with the crew at River Capital, it was clear that they not solely understood what we now have now however the place we’re going – which is in fact important.
“We reside in a time the place persons are excited but additionally terrified of AI so it’s pretty to have the ability to share our journey with pet homeowners and to utilise AI and machine studying to gas our learnings and evolution as an organization.”
Walters added: “We are delighted to help Ben and the crew and are impressed with the work in building out a extremely subtle expertise platform and a robust shopper checklist. Ben is a good man to work with too, his vitality is infectious and he’s genuinely open to our professional operational help.
“Growth within the sector is robust and we look ahead to supporting Vidivet to additional diversify their B2B buyer base.
“Health-tech is an space that can profit drastically by AI innovation and we see an actual alternative for the corporate to go on a excessive progress journey over the approaching years supported by deep studying initiatives with specialist veterinary well being innovation services and pharmaceutical companions.”
